financetom
IART
financetom
/
Healthcare
/
IART
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Integra LifeSciences Holdings CorporationIART
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care and otolaryngology.

It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services.

It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices.

In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia repair, peripheral nerve repair and protection, and tendon repair.

Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products.

The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally.

Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

Latest News >
Rhythm Pharmaceuticals Insider Sold Shares Worth $608,498, According to a Recent SEC Filing
Rhythm Pharmaceuticals Insider Sold Shares Worth $608,498, According to a Recent SEC Filing
Mar 20, 2024
07:31 AM EDT, 03/20/2024 (MT Newswires) -- Joseph Shulman, Chief Technical Officer, on March 19, 2024, sold 15,515 shares in Rhythm Pharmaceuticals ( RYTM ) for $608,498. Following the Form 4 filing with the SEC, Shulman has control over a total of 18,265 shares of the company, with 18,265 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1649904/000110465924036317/xslF345X03/tm249308-5_4seq1.xml ...
Temu operator PDD Holdings beats revenue estimates as e-commerce flourishes
Temu operator PDD Holdings beats revenue estimates as e-commerce flourishes
Mar 20, 2024
SHANGHAI, March 20 (Reuters) - Low-cost e-commerce giant PDD Holdings ( PDD ) beat Wall Street estimates for fourth-quarter revenue on Wednesday, driven by robust user growth and sales on its global platform Temu. U.S.-listed shares of the company, which is also home to Chinese online discount retailer Pinduoduo, rose more than 13% in premarket trading. PDD's revenue for the...
Microsoft to License AI Startup's Model, Inflection AI Says
Microsoft to License AI Startup's Model, Inflection AI Says
Mar 20, 2024
07:33 AM EDT, 03/20/2024 (MT Newswires) -- Microsoft ( MSFT ) will license artificial intelligence startup Inflection AI's technology, the startup said Tuesday, following the departure of most of its staff to Microsoft ( MSFT ). Inflection said it will soon host its latest large language model Inflection-2.5 on Microsoft's ( MSFT ) cloud platform Azure in a bid to...
HDFC Bank, TD Bank Group Partner to
HDFC Bank, TD Bank Group Partner to "Simplify Banking Experience" for Indian Students in Canada
Mar 20, 2024
06:57 AM EDT, 03/20/2024 (MT Newswires) -- HDFC Bank and TD Bank Group (TD.TO, TD) on Wednesday reported an expanded partnership to support Indian students planning to study in Canada. Under the partnership, TD and HDFC Bank have introduced a new referral program. HDFC Bank will refer students planning to study in Canada to TD's International Student GIC Program, which...
Copyright 2023-2026 - www.financetom.com All Rights Reserved